Literature DB >> 1913361

Parkinson's disease and exposure to rural environmental factors: a population based case-control study.

K M Semchuk1, E J Love, R G Lee.   

Abstract

To determine whether a history of exposure to rural environmental factors leads to an increased likelihood of developing idiopathic Parkinson's disease, we conducted a case-control study of 130 cases and 260 randomly selected community controls (matched with the cases by sex and age +/- 2.5 years at a ratio of 2 controls: 1 case) in the city of Calgary. The data were collected by personal interviews and were analyzed using conditional logistic regression for matched sets. The ages of the cases ranged from 36.5 to 90.7 years (mean = 68.5 +/- 11.3 years). The mean age at diagnosis was 61.1 +/- 12.4 years. The mean duration of disease was 7.8 +/- 0.6 years. Eleven (9.1%) cases were diagnosed before age 40. In this sample from the Province of Alberta, Canada, no significant increase in risk for Parkinson's disease was associated with a history of rural living, farm living, or well water drinking in early childhood or at any time during the first 45 years of life.

Entities:  

Mesh:

Year:  1991        PMID: 1913361     DOI: 10.1017/s0317167100031826

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  17 in total

1.  Disruption of dopamine transport by DDT and its metabolites.

Authors:  Jaime M Hatcher; Kristin C Delea; Jason R Richardson; Kurt D Pennell; Gary W Miller
Journal:  Neurotoxicology       Date:  2008-04-29       Impact factor: 4.294

Review 2.  The vesicular monoamine transporter 2: an underexplored pharmacological target.

Authors:  Alison I Bernstein; Kristen A Stout; Gary W Miller
Journal:  Neurochem Int       Date:  2014-01-04       Impact factor: 3.921

3.  β-Hexachlorocyclohexane levels in serum and risk of Parkinson's disease.

Authors:  Jason R Richardson; Ananya Roy; Stuart L Shalat; Brian Buckley; Bozena Winnik; Marla Gearing; Allan I Levey; Stewart A Factor; Padraig O'Suilleabhain; Dwight C German
Journal:  Neurotoxicology       Date:  2011-05-17       Impact factor: 4.294

Review 4.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

5.  Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits.

Authors:  Aysegul O Gezer; Joseph Kochmanski; Sarah E VanOeveren; Allyson Cole-Strauss; Christopher J Kemp; Joseph R Patterson; Kathryn M Miller; Nathan C Kuhn; Danielle E Herman; Alyssa McIntire; Jack W Lipton; Kelvin C Luk; Sheila M Fleming; Caryl E Sortwell; Alison I Bernstein
Journal:  Neurobiol Dis       Date:  2020-05-15       Impact factor: 5.996

6.  Pyrethroid pesticide-induced alterations in dopamine transporter function.

Authors:  Mohamed A Elwan; Jason R Richardson; Thomas S Guillot; W Michael Caudle; Gary W Miller
Journal:  Toxicol Appl Pharmacol       Date:  2005-07-11       Impact factor: 4.219

7.  Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system.

Authors:  Jaime M Hatcher; Jason R Richardson; Thomas S Guillot; Alison L McCormack; Donato A Di Monte; Dean P Jones; Kurt D Pennell; Gary W Miller
Journal:  Exp Neurol       Date:  2007-01-05       Impact factor: 5.330

Review 8.  Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease.

Authors:  Anumantha Kanthasamy; Huajun Jin; Suneet Mehrotra; Rajakishore Mishra; Arthi Kanthasamy; Ajay Rana
Journal:  Neurotoxicology       Date:  2009-12-11       Impact factor: 4.294

Review 9.  Idiopathic Parkinson's disease: epidemiology, diagnosis and management.

Authors:  Y Ben-Shlomo; K Sieradzan
Journal:  Br J Gen Pract       Date:  1995-05       Impact factor: 5.386

Review 10.  Vesicular integrity in Parkinson's disease.

Authors:  Shawn P Alter; Gina M Lenzi; Alison I Bernstein; Gary W Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.